Stock News

Finemark National Bank & Trust Has Cut Gilead Sciences (GILD) Stake By $653,670; 1 Analysts Bullish Constellation Software Inc. (TSE:CSU)

Among 4 analysts covering Constellation Software Inc. (TSE:CSU), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 25% are positive. Constellation Software Inc. had 39 analyst reports since July 31, 2015 according to SRatingsIntel. The firm earned “” rating on Friday, October 16 by RBC Capital Markets. The rating was upgraded by National Bank Canada to “Sector Perform” on Friday, October 30. The stock has “Outperform” rating by RBC Capital Markets on Monday, February 22. Scotia Capital maintained it with “Sector Outperform” rating and $550 target in Friday, July 31 report. RBC Capital Markets maintained Constellation Software Inc. (TSE:CSU) on Monday, January 4 with “Sector Perform” rating. The firm has “Outperform” rating by RBC Capital Markets given on Monday, April 3. Scotia Capital maintained it with “Outperform” rating and $555 target in Monday, June 6 report. The stock of Constellation Software Inc. (TSE:CSU) earned “Market Perform” rating by BMO Capital Markets on Monday, May 1. The stock of Constellation Software Inc. (TSE:CSU) has “Sector Perform” rating given on Friday, April 21 by Scotia Capital. The rating was maintained by RBC Capital Markets on Monday, January 16 with “Outperform”. See Constellation Software Inc. (TSE:CSU) latest ratings:

20/10/2017 Broker: RBC Capital Markets Rating: Outperform Old Target: $700.00 New Target: $850.00 Target Up

Finemark National Bank & Trust decreased Gilead Sciences Inc (GILD) stake by 37.86% reported in 2017Q3 SEC filing. Finemark National Bank & Trust sold 8,070 shares as Gilead Sciences Inc (GILD)’s stock declined 8.05%. The Finemark National Bank & Trust holds 13,246 shares with $1.07M value, down from 21,316 last quarter. Gilead Sciences Inc now has $105.42 billion valuation. The stock decreased 1.04% or $0.85 during the last trading session, reaching $80.7. About 7.55M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since February 18, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

The stock decreased 0.38% or $3.17 during the last trading session, reaching $837.68. About 48,194 shares traded or 16.34% up from the average. Constellation Software Inc. (TSE:CSU) has 0.00% since February 18, 2017 and is . It has underperformed by 16.70% the S&P500.

Investors sentiment increased to 1.86 in Q3 2017. Its up 1.08, from 0.78 in 2017Q2. It increased, as 8 investors sold Constellation Software Inc. shares while 20 reduced holdings. 13 funds opened positions while 39 raised stakes. 29.11 million shares or 2.56% more from 28.38 million shares in 2017Q2 were reported. Bnp Paribas Arbitrage Sa owns 4,355 shares. Jefferies Grp Limited Liability Company invested 0% in Constellation Software Inc. (TSE:CSU). Pnc Fin Serv Grp Inc holds 0% or 30 shares. 631,641 are owned by Northern. Great West Life Assurance Communication Can holds 2,100 shares or 0% of its portfolio. State Board Of Administration Of Florida Retirement holds 0% or 24,604 shares in its portfolio. Idaho-based Caprock Group Inc Incorporated has invested 0.05% in Constellation Software Inc. (TSE:CSU). Moreover, Us Bank De has 0% invested in Constellation Software Inc. (TSE:CSU) for 1,830 shares. Ubs Asset Mgmt Americas Inc reported 0% in Constellation Software Inc. (TSE:CSU). Moreover, Citadel Advisors Limited Com has 0% invested in Constellation Software Inc. (TSE:CSU) for 174,318 shares. Nationwide Fund Advsrs reported 0% of its portfolio in Constellation Software Inc. (TSE:CSU). Morgan Stanley accumulated 0% or 171,770 shares. State Street accumulated 0% or 638,361 shares. The California-based Falcon Point Ltd Limited Liability Company has invested 1.5% in Constellation Software Inc. (TSE:CSU). Schafer Cullen Management Inc invested 0% in Constellation Software Inc. (TSE:CSU).

Constellation Software Inc., together with its subsidiaries, engages in the development, installation, and customizations of software to various industries in the public and private sector markets primarily in the United States, Canada, the United Kingdom, Europe, and internationally. The company has market cap of $17.75 billion. The firm operates through two divisions, Public Sector and Private Sector. It has a 80.01 P/E ratio. The Public Sector segment develops and distributes software solutions primarily to government and government-related customers.

Since August 30, 2017, it had 0 buys, and 13 insider sales for $51.09 million activity. $4.18M worth of Gilead Sciences, Inc. (NASDAQ:GILD) was sold by MARTIN JOHN C. The insider Washington Robin L sold 51,820 shares worth $4.40M. Another trade for 60,000 shares valued at $4.99 million was made by Meyers James R on Thursday, August 31. Shares for $2.37M were sold by Alton Gregg H on Thursday, January 11.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 124 analyst reports since July 29, 2015 according to SRatingsIntel. Cowen & Co maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Wednesday, February 7. Cowen & Co has “Buy” rating and $90.0 target. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Buy” rating by Needham on Wednesday, July 29. The stock has “Buy” rating by Maxim Group on Friday, February 12. RBC Capital Markets maintained the shares of GILD in report on Wednesday, February 3 with “Outperform” rating. The firm earned “Buy” rating on Thursday, August 31 by William Blair. The firm earned “Mkt Perform” rating on Tuesday, September 27 by Leerink Swann. The stock has “Market Perform” rating by Leerink Swann on Thursday, October 5. Jefferies maintained the stock with “Hold” rating in Tuesday, March 15 report. As per Tuesday, July 25, the company rating was maintained by Mizuho. On Friday, October 6 the stock rating was maintained by Morgan Stanley with “Equal-Weight”.

Finemark National Bank & Trust increased Mondelez Intl Inc (NASDAQ:MDLZ) stake by 29,234 shares to 146,617 valued at $5.96M in 2017Q3. It also upped Merck & Co Inc (NYSE:MRK) stake by 39,096 shares and now owns 215,868 shares. Ishares Tr (EEM) was raised too.

Leave a Reply

Your email address will not be published. Required fields are marked *